First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Shares Up 1.6% – Here’s What Happened

Shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) rose 1.6% on Thursday . The company traded as high as $38.59 and last traded at $38.52. 14,818 shares traded hands during trading, an increase of 30% from the average session volume of 11,400 shares. The stock had previously closed at $37.92.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The stock has a market cap of $36.59 million, a PE ratio of 14.51 and a beta of 0.45. The company has a 50-day simple moving average of $36.10 and a 200-day simple moving average of $34.82.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Thursday, June 25th were issued a dividend of $0.092 per share. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06. This represents a $0.37 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend was Thursday, June 25th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Vivaldi Capital Management LP lifted its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after acquiring an additional 1,741 shares during the period. OLD Mission Capital LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter worth approximately $528,000. Kestra Advisory Services LLC purchased a new position in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at approximately $59,000. Commonwealth Equity Services LLC purchased a new position in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at approximately $237,000. Finally, LPL Financial LLC increased its stake in First Trust Nasdaq Pharmaceuticals ETF by 40.5% in the 4th quarter. LPL Financial LLC now owns 146,105 shares of the company’s stock valued at $4,813,000 after purchasing an additional 42,147 shares in the last quarter.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.